News | August 03, 2021
Evexia Lifecare to manufacture API of Isometa
Robust demand for the product across the Middle East, Africa and Latin America
Robust demand for the product across the Middle East, Africa and Latin America
The govt has rolled out three schemes for promoting the manufacture of API
Turnover of API division of ISLL stood at Rs 856.58 crore
The company proposes to utilise the net proceeds from the fresh issue towards payment of outstanding purchase consideration
The company confirms an upward revision to its 2021 Outlook, reflecting the expectation to achieve mid-teens CER sales growth
The US FDA has closed the observations pertaining to this audit with an Establishment Inspection Report on the 20th of July 2021
The distribution agreement is effective from 1 October 2021 and applies to Bormed products used in pharmaceutical packaging, medical and diagnostic devices
This will enable Mangalam to reduce its reliability on Chinese imports for this product and also help to maintain an uninterrupted supply chain to a great extent
The company has launched Perampil, at 2 mg (Rs. 49/strip of 7 tablets), 4 mg (Rs. 180/strip of 15 tablets) and 6 mg (Rs. 300/strip of 15 tablets) to improve patient access
Researchers observed that a form of vitamin D, known as 25-hydroxyvitamin D3 (Calcifediol), was absorbed faster and better than the same dose of vitamin D.
Subscribe To Our Newsletter & Stay Updated
